Showing results (1711-1720 of 1,799) with videos related to

Sort By:
Pageof 180
The Journal of Clinical Investigation|June 5, 2003
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolatesHarlan D Caldwell, Heidi Wood, Debbie Crane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2013
Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapiesMichal J Besser, Ronnie Shapira-Frommer, Orit Itzhaki, et al.
The Journal of Rheumatology|October 21, 1999
A disease severity scale for systemic sclerosis: development and testingT A Medsger, A J Silman, V D Steen, et al.
The Lancet. Oncology|July 27, 2019
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 studyCaroline Robert, Antoni Ribas, Jacob Schachter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Randomized, Double-Blind, Phase III LEAP-003 Study of First-Line Lenvatinib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab for Unresectable or Metastatic MelanomaA Arance, M-A Berciano-Guerrero, J Guo, et al.
The New England Journal of Medicine|September 12, 2017
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated MelanomaGeorgina V Long, Axel Hauschild, Mario Santinami, et al.
Pharmacogenetics|August 1, 1997
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergenceP I Mackenzie, I S Owens, B Burchell, et al.
JAMA Oncology|July 17, 2020
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical TrialsIgor Puzanov, Antoni Ribas, Caroline Robert, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2017
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanomaOmid Hamid, Igor Puzanov, Reinhard Dummer, et al.
Journal for the Scientific Study of Religion|May 20, 2021
Religion and Spirituality among American Indian, South Asian, Black, Hispanic/Latina, and White Women in the Study on Stress, Spirituality, and HealthBlake Victor Kent, James C Davidson, Ying Zhang, et al.
Pageof 180